NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)
This study has been completed.
Sponsor:
Ludwig Institute for Cancer Research
Collaborator:
American Society of Clinical Oncology
Information provided by:
Ludwig Institute for Cancer Research
ClinicalTrials.gov Identifier:
NCT00142454
First received: September 1, 2005
Last updated: September 20, 2007
Last verified: September 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2007 |
| Estimated Primary Completion Date: | No date given |